# SANA (Sana Biotechnology, Inc.) - SEC EDGAR Financial Statements

> Sana Biotechnology, Inc. reported $376.1M in total assets and a net loss of $149.3M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/SANA
- Markdown: https://convexityos.com/fundamentals/SANA.md
- SEC CIK: 0001770121
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:33 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001770121&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$156.7M | Operating profit |
| Net Income | FY 2025 | -$149.3M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.48 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$145.1M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $121.7M | Total debt: $53.84M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $132.0M | $215.7M | $261.8M | $285.9M | $248.6M | $132.9M | $99.59M |
| Total Operating Expenses | $250.3M | $272.7M | $293.1M | $272.6M | $356.9M | $286.1M | $141.2M |
| **Operating Income** | -$250.3M | -$272.7M | -$293.1M | -$272.6M | -$356.9M | -$286.1M | -$141.2M |
| **EBITDA** | -$237.5M | -$257.2M | -$275.6M | -$257.0M | -$345.8M | -$280.2M | -$139.3M |
| Income Before Tax | -- | -- | -- | -- | -$355.9M | -$285.3M | -$138.3M |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -$7.55M |
| **Net Income** | -$244.2M | -$266.8M | -$283.3M | -$269.5M | -$355.9M | -$285.3M | -$130.8M |
| Basic EPS | -$0.96 | -$1.16 | -$1.46 | -$1.43 | -$2.14 | -$21.92 | -$26.68 |
| **Diluted EPS** | -$0.96 | -$1.16 | -$1.46 | -$1.43 | -$2.14 | -$21.92 | -$26.68 |
| Basic Shares Outstanding | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M | 13.0M | 4.9M |
| Diluted Shares Outstanding | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M | 13.0M | 4.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $33.93M | $30.73M | $28.72M | $34.92M | $30.11M | $29.76M | $37.19M | $45.15M |
| Total Operating Expenses | -$18.51M | $65.42M | $48.61M | $61.20M | $43.52M | $94.97M | $50.63M | $50.87M |
| **Operating Income** | $18.51M | -$65.42M | -$48.61M | -$61.20M | -$43.52M | -$94.97M | -$50.63M | -$50.87M |
| **EBITDA** | $21.51M | -$63.22M | -$46.22M | -$58.10M | -$40.31M | -$92.08M | -$46.98M | -$47.06M |
| **Net Income** | $20.40M | -$63.63M | -$47.21M | -$58.83M | -$42.15M | -$93.80M | -$49.39M | -$49.07M |
| Basic EPS | $0.07 | -$0.22 | -$0.17 | -- | -$0.16 | -$0.39 | -$0.21 | -- |
| **Diluted EPS** | $0.07 | -$0.22 | -$0.17 | -- | -$0.16 | -$0.39 | -$0.21 | -- |
| Basic Shares Outstanding | 307.0M | 295.7M | 276.9M | -- | 260.5M | 238.4M | 237.6M | -- |
| Diluted Shares Outstanding | 308.8M | 295.7M | 276.9M | -- | 260.5M | 238.4M | 237.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $71.87M | $127.6M | $133.5M | $176.8M | $253.0M | $124.8M |
| Short-Term Investments | $66.51M | $24.93M | $71.68M | $247.2M | $298.0M | $253.5M |
| **Cash & Short-Term Investments** | $138.4M | $152.5M | $205.2M | $424.0M | $551.0M | $378.3M |
| **Total Current Assets** | $148.7M | $160.8M | $213.5M | $444.4M | $558.1M | $384.5M |
| Property, Plant & Equipment, Net | $26.91M | $77.31M | $70.69M | $66.92M | $65.46M | $46.77M |
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M |
| Intangible Assets | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M |
| Long-Term Investments | -- | -- | -- | $10.05M | $195.9M | $33.73M |
| Other Non-Current Assets | $3.17M | $5.12M | $6.37M | $4.60M | $5.00M | $190K |
| **Total Non-Current Assets** | $268.2M | $340.2M | $351.8M | $378.3M | $571.3M | $345.8M |
| **Total Assets** | $416.9M | $501.0M | $565.3M | $822.7M | $1.13B | $730.3M |
| Accounts Payable | $1.67M | $5.21M | $4.11M | $2.86M | $2.22M | $2.25M |
| **Total Current Liabilities** | $78.73M | $45.43M | $64.49M | $111.5M | $99.23M | $31.45M |
| Other Non-Current Liabilities | $10.60M | $9.90M | -- | -- | -- | $540K |
| **Total Non-Current Liabilities** | $177.3M | $205.1M | $213.3M | $211.9M | $301.7M | $267.1M |
| **Total Liabilities** | $256.0M | $250.5M | $277.8M | $323.4M | $400.9M | $298.6M |
| **Total Debt (incl. Leases)** | $78.86M | $94.20M | $104.1M | $108.3M | $110.9M | $71.91M |
| Common Stock | $27K | $22K | $20K | $19K | $18K | $2.0K |
| Retained Earnings | -$1.85B | -$1.60B | -$1.34B | -$1.05B | -$785.4M | -$429.4M |
| Accumulated Other Comp. Income | $28K | $14K | -$60K | -$4.33M | -$1.37M | $30K |
| **Total Stockholders' Equity** | $160.9M | $250.5M | $287.5M | $499.3M | $728.5M | -$421.2M |
| Total Equity | $160.9M | $250.5M | $287.5M | $499.3M | $728.5M | -$421.2M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.10M | $57.07M | $83.80M | $71.87M | $103.4M | $71.27M | $96.13M | $127.6M |
| Short-Term Investments | $80.62M | $103.4M | $17.34M | $66.51M | $49.70M | $1.40M | $8.57M | $24.93M |
| **Cash & Short-Term Investments** | $121.7M | $160.5M | $101.1M | $138.4M | $153.1M | $72.67M | $104.7M | $152.5M |
| **Total Current Assets** | $132.3M | $170.6M | $111.7M | $148.7M | $161.8M | $82.50M | $112.7M | $160.8M |
| Property, Plant & Equipment, Net | $23.11M | $25.16M | $25.67M | $26.91M | $29.93M | $33.08M | $73.69M | $77.31M |
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M |
| Intangible Assets | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M | $59.20M |
| Other Non-Current Assets | $551K | $552K | $563K | $3.17M | $3.22M | $3.22M | $4.39M | $5.12M |
| **Total Non-Current Assets** | $243.8M | $260.9M | $261.9M | $268.2M | $273.7M | $279.1M | $332.7M | $340.2M |
| **Total Assets** | $376.1M | $431.5M | $373.6M | $416.9M | $435.4M | $361.6M | $445.5M | $501.0M |
| Accounts Payable | $1.95M | $1.36M | $2.12M | $1.67M | $1.86M | $2.27M | $989K | $5.21M |
| **Total Current Liabilities** | $74.88M | $123.8M | $86.27M | $78.73M | $35.51M | $33.44M | $33.16M | $45.43M |
| Other Non-Current Liabilities | $9.08M | $9.48M | $9.80M | $10.60M | $7.88M | $8.24M | $9.44M | $9.90M |
| **Total Non-Current Liabilities** | $120.9M | $153.2M | $168.1M | $177.3M | $204.6M | $205.6M | $203.2M | $205.1M |
| **Total Liabilities** | $195.8M | $277.0M | $254.4M | $256.0M | $240.1M | $239.1M | $236.4M | $250.5M |
| **Total Debt (incl. Leases)** | $53.84M | $73.74M | $75.33M | $78.86M | $82.24M | $85.49M | $91.31M | $94.20M |
| Common Stock | $30K | $30K | $27K | $27K | $26K | $23K | $23K | $22K |
| Retained Earnings | -$1.94B | -$1.96B | -$1.90B | -$1.85B | -$1.79B | -$1.75B | -$1.65B | -$1.60B |
| Accumulated Other Comp. Income | -$104K | -$66K | -$2.0K | $28K | $21K | $0 | $0 | $14K |
| **Total Stockholders' Equity** | $180.4M | $154.6M | $119.2M | $160.9M | $195.3M | $122.6M | $209.1M | $250.5M |
| Total Equity | $180.4M | $154.6M | $119.2M | $160.9M | $195.3M | $122.6M | $209.1M | $250.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$244.2M | -$266.8M | -$283.3M | -$269.5M | -$355.9M | -$285.3M | -$130.8M |
| Depreciation & Amortization | $12.80M | $15.50M | $17.50M | $15.60M | $11.10M | $5.92M | $1.83M |
| Stock-Based Compensation | $25.46M | $37.68M | $35.53M | $38.34M | $22.36M | $5.83M | $1.50M |
| Change in Payables | -$3.54M | $1.38M | $1.03M | $1.06M | -$266K | $1.98M | -$421K |
| **Operating Cash Flow** | -$143.8M | -$223.2M | -$253.6M | -$290.1M | -$251.1M | -$138.0M | -$85.52M |
| Capital Expenditure | -$938K | -$33.43M | -$20.03M | -$20.88M | -$29.86M | -$23.87M | -$26.12M |
| **Free Cash Flow** | -$144.8M | -$256.6M | -$273.6M | -$310.9M | -$280.9M | -$161.9M | -$111.6M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -$3.19M |
| Purchases of Investments | -$87.29M | -$226.1M | -$157.7M | -$78.69M | -$491.4M | -$387.4M | -$141.5M |
| **Investing Cash Flow** | -$40.24M | $17.45M | $172.0M | $210.6M | -$245.8M | -$252.6M | -$87.86M |
| Common Stock Issued | $126.4M | $181.0M | $27.02M | $4.31M | $5.35M | -- | -- |
| **Financing Cash Flow** | $128.7M | $199.7M | $31.65M | $4.91M | $631.8M | $435.7M | $223.7M |
| **Net Change in Cash** | -$55.33M | -$5.95M | -$49.92M | -$74.58M | $134.9M | $45.14M | $50.36M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $20.40M | -$63.63M | -$47.21M | -$58.83M | -$42.15M | -$93.80M | -$49.39M | -$49.07M |
| Depreciation & Amortization | $3.00M | $2.20M | $2.39M | $3.10M | $3.20M | $2.90M | $3.65M | $3.80M |
| Stock-Based Compensation | $5.33M | $5.34M | $5.66M | $6.34M | $5.48M | $6.63M | $7.02M | $6.44M |
| Change in Payables | $551K | -$851K | $454K | -$189K | -$357K | $1.23M | -$4.22M | $2.28M |
| **Operating Cash Flow** | -$38.75M | -$32.79M | -$37.38M | -$32.64M | -$29.43M | -$33.10M | -$48.66M | -$47.16M |
| Capital Expenditure | -$791K | -$1.62M | -$288K | -$873K | -$41K | $112K | -$136K | -$436K |
| **Free Cash Flow** | -$39.54M | -$34.41M | -$37.67M | -$33.51M | -$29.47M | -$32.99M | -$48.79M | -$47.60M |
| Purchases of Investments | -$16.11M | -$101.7M | -$5.59M | -$36.08M | -$49.53M | $0 | -$1.68M | -$13.08M |
| **Investing Cash Flow** | $22.35M | -$87.52M | $49.44M | -$16.50M | -$48.02M | $7.68M | $16.60M | $47.09M |
| **Financing Cash Flow** | $0 | $93.58M | -$128K | $17.65M | $109.5M | $561K | $982K | $643K |
| **Net Change in Cash** | -$16.40M | -$26.73M | $11.93M | -$31.49M | $32.09M | -$24.86M | -$31.07M | $570K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -151.8% | -106.5% | -98.5% | -54.0% | -48.9% | -- | -- |
| Return on Assets (ROA) | -58.6% | -53.2% | -50.1% | -32.8% | -31.5% | -39.1% | -- |
| Current Ratio | 1.89x | 3.54x | 3.31x | 3.99x | 5.62x | 12.22x | -- |
| Quick Ratio | 1.76x | 3.36x | 3.18x | 3.80x | 5.55x | 12.03x | -- |
| Debt to Equity | 0.49x | 0.38x | 0.36x | 0.22x | 0.15x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -82.8% | -137.0% | -202.9% | -151.8% | -120.0% | -205.8% | -99.8% | -106.5% |
| Return on Assets (ROA) | -39.7% | -49.1% | -64.8% | -58.6% | -53.8% | -69.7% | -46.8% | -53.2% |
| Current Ratio | 1.77x | 1.38x | 1.29x | 1.89x | 4.55x | 2.47x | 3.40x | 3.54x |
| Quick Ratio | 1.63x | 1.30x | 1.17x | 1.76x | 4.31x | 2.17x | 3.16x | 3.36x |
| Debt to Equity | 0.30x | 0.48x | 0.63x | 0.49x | 0.42x | 0.70x | 0.44x | 0.38x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
